ISSN: 2167-065X

Клиническая фармакология и биофармацевтика

Открытый доступ

Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.

 

Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей

Абстрактный

Experience and Attitudes of Pharmacy Groups towards Suicide Prevention: A Cross-Sectional Survey

David Gardner

Community pharmacist’s area unit progressively recognized as integral members in suicide bar programs, as a part of a multidisciplinary and multifarious approach. However, additional analysis is needed to grasp then optimize the full pharmacy teams’ role across sectors. To explore pharmacy teams’ expertise of, and attitudes towards, suicide bar in England.A cross-sectional survey was purposively distributed to pharmacy employees in England before accessing associate nonmandatory suicide awareness raising video, hosted by Centre for Pharmacy Postgraduate Education (CPPE), in September 2019–March 2021. Queries enclosed demographics and skill of, attitudes towards, and state for, suicide bar. The 14-item Attitudes to Suicide bar (ASP) scale was used (possible vary 14–70 with lower scores representing positive attitudes). Descriptive and comparative statistics were reported. Free-text comments were invited to explore respondents’ expertise of suicide bar and reflexive thematic analysis used. Pharmacy groups felt responsibility in caring for those in danger of suicide and had expertise of this. Additional coaching ought to embody understanding of medicines means that restriction and involve all roles and sectors of pharmacy. Pharmacy groups ought to be integrated into the ‘circle of care’ to access referral pathways.

Отказ от ответственности: Этот реферат был переведен с помощью инструментов искусственного интеллекта и еще не прошел проверку или верификацию.